NanoVita Raises Seed Round for Health Research Protocol

NanoVita, a decentralized science protocol for health research, closed a seed round at a $10 million fully diluted valuation. The funding, announced on March 31, 2026, will help the project expand its work combining nanotechnology, AI, and blockchain for data sharing. The round supports building infrastructure for health studies using real-world data.

The protocol mixes nanotech with AI-driven biological analysis and uses blockchain to manage health data. DeSci projects have been attracting more capital lately as Web3 builders push for alternatives to traditional research funding. NanoVita wants to make health data sharing easier by removing some of the barriers in centralized systems.

| Funding Detail | Information | |----------------|-------------| | Project | NanoVita | | Sector | Decentralized Science (DeSci) / Health Research | | Round Stage | Seed | | Valuation | $10 million FDV | | Amount Raised | Undisclosed (FDV-based round) | | Lead Investor | Cryptogram Venture (CGV) | | Notable Participants | UNIVERSE-DIMENSIONAL SPACE PTE. LTD., Candaq Fintech Group, Susie Ventures (BVI) | | Announcement Date | March 31, 2026 | | Disclosure Gaps | Specific amount raised not specified; use of funds tied to ecosystem expansion |

The investor list includes established crypto and fintech names, showing targeted interest in health-focused blockchain applications. These backers seem to see potential in DeSci's direction, where protocols like NanoVita try to use distributed tech for research.

Health Blockchain Projects Continue Raising in Q1

With the round closed, NanoVita plans to speed up development in nanotechnology and AI bio-intelligence, using blockchain to manage health data. The timing fits with broader interest in DeSci as similar projects explore biotech and distributed ledgers.

NanoVita's protocol aims to build infrastructure for collaborative health research without traditional gatekeepers. Cryptogram Venture (CGV) led the round, joined by UNIVERSE-DIMENSIONAL SPACE PTE. LTD. (Singapore-based), Candaq Fintech Group, and Susie Ventures (BVI). The actual amount raised wasn't disclosed—just the $10 million valuation, which is common for early-stage Web3 deals.

What the funding includes:

• CGV leading, bringing experience in crypto and emerging tech to guide the project.
• UNIVERSE-DIMENSIONAL SPACE PTE. LTD. (UDS) adding international fintech perspective.
• Candaq Fintech Group and Susie Ventures rounding out the group with blockchain experience.
• Money going toward nanotechnology and AI work for decentralized research.
• A bet that DeSci protocols can compete with centralized health data systems.

This raise comes as Web3 health projects continue to attract capital. NanoVita's approach—using real health data with a focus on transparency—puts it in a specific niche. No further rounds or token details were mentioned; the focus stays on seed-stage building.

The funding lets NanoVita work toward an open health research framework using blockchain for data integrity. This fits the ongoing pattern of money flowing into DeSci, where projects try to connect emerging tech with decentralized systems. The investors seem to think the protocol can contribute to transparent research infrastructure, though no timelines were shared.

Compared to other DeSci projects, NanoVita's AI bio-intelligence integration could offer different tools for health data analysis. The FDV-based round structure is standard for early Web3 funding. Reports across crypto news outlets match up on the investor list and valuation.

As Q1 2026 ends, this seed round shows continued investment in niche Web3 sectors, especially where health meets AI. Whether NanoVita delivers depends on building out its ecosystem and data sharing features. The diverse investor group gives it a starting point, in a market that's been receptive to DeSci protocols.

Bottom line: Investors are still backing DeSci, with health-blockchain projects continuing to raise.